Related Experiment Video

Updated: May 16, 2026

Rearing the Cabbage White Butterfly (Pieris rapae) in Controlled Conditions: A Case Study with Heavy Metal Tolerance
08:08

Rearing the Cabbage White Butterfly (Pieris rapae) in Controlled Conditions: A Case Study with Heavy Metal Tolerance

Published on: August 18, 2023

Are children still at risk for lead poisoning?

James R Roberts1, Cindy L Allen, Colin Ligon

  • 1Medical University of South Carolina, Charleston, SC 29425, USA. robertsj@musc.edu

Clinical Pediatrics
|November 17, 2012
PubMed

Insights

Identifying children at risk for elevated blood lead levels (EBLLs) is challenging due to decreased national prevalence. Parental reports revealed lead-based paint in nearly 30% of homes, indicating ongoing environmental lead exposure risks.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Public Health

Background:

  • National decrease in elevated blood lead levels (EBLLs) presents screening challenges.
  • Focus on identifying at-risk children in communities with known lead hazards.

Purpose of the Study:

  • To assess the prevalence of EBLLs in a high-risk community.
  • To identify lead exposure risk factors through parental questionnaires.

Main Methods:

  • Community-based screening of children using field-administered capillary blood lead tests.
  • Parental questionnaires collected data on environmental, behavioral, and knowledge-based lead risk factors.

Main Results:

  • One child (1.3%) had a confirmed venous blood lead level >10 µg/dL.
  • A median of two risk factors were reported per child across domains.
  • Parental reports indicated lead-based paint in 29% of homes.

Conclusions:

  • Despite low EBLL prevalence, significant lead-based paint presence highlights persistent environmental risk.
  • Parental reporting is a valuable tool for identifying potential lead exposure in children.
Abstract

More Related Videos

Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory06:00

Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory

Published on: July 10, 2018

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...